← Eichor
Condition: Carcinoma Basal Cell Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Carcinoma Basal Cell

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalised Immunotherapy Platform
Phase N/A · 3 location(s) · Melanoma Institute Australia · NCT06536257
Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
Phase 2 · 3 location(s) · University of California, San Diego · NCT06624475
L19IL2/TNF in Patients With Basal Cell Carcinoma
Phase 2 · 18 location(s) · Philogen S.p.A. · NCT07227870
Raman Spectroscopy and Skin Cancer
Phase N/A · 1 location(s) · Tiezhi Zhang · NCT06384924
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
NA · 1 location(s) · University of Rochester · NCT06473103
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860
Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07201012
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Phase 1/Phase 2 · 3 location(s) · MediWound Ltd · NCT05157763
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
Phase 2 · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06112522
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Phase N/A · 8 location(s) · Maastricht University Medical Center · NCT05463757
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
EARLY_Phase 1 · 2 location(s) · Marissa Lobl · NCT07286318
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Phase 1/Phase 2 · 4 location(s) · Instituto Oncológico Dr Rosell · NCT07251413
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients
Phase 1 · 1 location(s) · Rise Therapeutics LLC · NCT06398418
AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images
Phase N/A · 1 location(s) · Istanbul Training and Research Hospital · NCT07677124
Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma
Phase 3 · 1 location(s) · University of Sao Paulo · NCT07381972
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
EARLY_Phase 1 · 1 location(s) · University of California, Irvine · NCT07628634
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
Phase 2 · 7 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06981325
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05859074
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Phase N/A · 1 location(s) · Societa Italiana di Dermatologia Medica, Chirurgica, Estetic · NCT06309836
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
NA · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06907095
Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT06330350
Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07241585
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metasta
Phase 1/Phase 2 · 26 location(s) · National Cancer Institute (NCI) · NCT05896839
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Phase N/A · 4 location(s) · Vanderbilt University Medical Center · NCT00898638
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
Phase N/A · 1 location(s) · EuMelaReg gGmbH · NCT05741073
Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
Phase N/A · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07215988
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.